Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1089/ast.2008.0802 | DOI Listing |
Acta Neuropathol
January 2025
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Acta Neuropathol
November 2024
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Clin Endocrinol (Oxf)
September 2024
Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, UK.
Context: Head and neck paragangliomas (HNPGLs) are rare, usually benign, slow-growing tumours arising from neural crest-derived tissue. Definitive management pathways for HNPGLs have yet to be clearly defined.
Objective: To review our experience of the clinical features and management of these tumours and to analyse outcomes of different treatment modalities.
Am J Speech Lang Pathol
November 2023
School of Nursing, University of North Carolina at Chapel Hill.
Purpose: Infants with perceived feeding problems are frequently referred for assessment of their feeding abilities. However, little is known regarding how healthy nondysphagic infants perform on commonly used assessments, making determination of impairment difficult. The aim of this investigation was to elucidate the characteristics of healthy term infant feeding performance using three commonly employed clinical assessments: Neonatal Eating Assessment Tool-Mixed (NeoEat-Mixed), Oral Feeding Scale, and Early Feeding Skills (EFS).
View Article and Find Full Text PDFBJR Open
April 2023
Cancer Centre Belfast City Hospital, Belfast Health & Social Care Trust, Lisburn Road, Belfast, Northern Ireland.
Objective: Interstitial lung disease (ILD) is relatively common in patients with lung cancer with an incidence of 7.5%. Historically pre-existing ILD was a contraindication to radical radiotherapy owing to increased radiation pneumonitis rates, worsened fibrosis and poorer survival compared with non-ILD cohorts.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!